Frontiers in Immunology (Dec 2021)

Antcin K Inhibits TNF-α, IL-1β and IL-8 Expression in Synovial Fibroblasts and Ameliorates Cartilage Degradation: Implications for the Treatment of Rheumatoid Arthritis

  • David Achudhan,
  • Shan-Chi Liu,
  • Yen-You Lin,
  • Chien-Chung Huang,
  • Chien-Chung Huang,
  • Chun-Hao Tsai,
  • Chun-Hao Tsai,
  • Chih-Yuan Ko,
  • I-Ping Chiang,
  • Yueh-Hsiung Kuo,
  • Yueh-Hsiung Kuo,
  • Yueh-Hsiung Kuo,
  • Chih-Hsin Tang,
  • Chih-Hsin Tang,
  • Chih-Hsin Tang,
  • Chih-Hsin Tang

DOI
https://doi.org/10.3389/fimmu.2021.790925
Journal volume & issue
Vol. 12

Abstract

Read online

Extracts from Taiwan’s traditional medicinal mushroom, Antrodia cinnamomea, exhibit anti-inflammatory activities in cellular and preclinical studies. However, this paper is the first to report that Antcin K, a triterpenoid isolated from A. cinnamomea, inhibits proinflammatory cytokine production in human rheumatoid synovial fibroblasts (RASFs), which are major players in rheumatoid arthritis (RA) disease. In our analysis of the mechanism of action, Antcin K inhibited the expression of three cytokines (tumor necrosis factor alpha [TNF-α], interleukin 1 beta [IL-1β] and IL-8) in human RASFs; cytokines that are crucial to RA synovial inflammation. Notably, incubation of RASFs with Antcin K reduced the phosphorylation of the focal adhesion kinase (FAK), phosphoinositide 3-kinase (PI3K), protein kinase B (AKT) and nuclear factor-κB (NF-κB) signaling cascades, all of which promote cytokine production in RA. Intraperitoneal injections of Antcin K (10 mg/kg or 30 mg/kg) attenuated paw swelling, cartilage degradation and bone erosion, and decreased serum levels of TNF-α, IL-1β, IL-8 in collagen-induced arthritis (CIA) mice; in further experiments, IL-6 levels were similarly reduced. The inhibitory effects of Antcin K upon TNF-α, IL-1β and IL-8 expression in human RASFs was achieved through the downregulation of the FAK, PI3K, AKT and NF-κB signaling cascades. Our data support clinical investigations using Antcin K in RA disease.

Keywords